Aldeyra Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2014 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Aldeyra Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2014 to Q2 2024.
  • Aldeyra Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 29, 2024 was 59.4M shares, a 1.41% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 59.4M +826K +1.41% Jul 29, 2024 10-Q 2024-08-01
Q1 2024 58.9M +319K +0.55% Mar 6, 2024 10-K 2024-03-07
Q3 2023 58.8M +262K +0.45% Oct 31, 2023 10-Q 2023-11-03
Q2 2023 58.6M +273K +0.47% Aug 1, 2023 10-Q 2023-08-03
Q1 2023 58.6M +477K +0.82% Apr 21, 2023 10-K/A 2023-04-28
Q3 2022 58.6M +468K +0.81% Nov 8, 2022 10-Q 2022-11-10
Q2 2022 58.3M +459K +0.79% Aug 2, 2022 10-Q 2022-08-05
Q1 2022 58.1M +10.9M +23% Mar 15, 2022 10-K 2022-03-17
Q3 2021 58.1M +19.3M +49.6% Oct 26, 2021 10-Q 2021-10-28
Q2 2021 57.9M +19.2M +49.8% Aug 3, 2021 10-Q 2021-08-05
Q1 2021 47.2M +17.6M +59.3% Mar 8, 2021 10-K 2021-03-11
Q3 2020 38.8M +10.9M +38.9% Nov 3, 2020 10-Q 2020-11-05
Q2 2020 38.6M +11.1M +40.1% Aug 4, 2020 10-Q 2020-08-06
Q1 2020 29.7M +2.27M +8.27% Mar 10, 2020 10-K 2020-03-12
Q3 2019 28M +1.71M +6.51% Nov 7, 2019 10-Q 2019-11-07
Q2 2019 27.6M +6.6M +31.5% Aug 9, 2019 10-Q 2019-08-09
Q1 2019 27.4M +7.73M +39.3% Mar 8, 2019 10-K 2019-03-08
Q3 2018 26.2M +7.13M +37.3% Nov 14, 2018 10-Q 2018-11-14
Q2 2018 21M +5.82M +38.4% Aug 9, 2018 10-Q 2018-08-09
Q1 2018 19.7M +4.53M +30% Mar 29, 2018 10-K 2018-03-29
Q3 2017 19.1M +6.54M +52% Nov 9, 2017 10-Q 2017-11-09
Q2 2017 15.2M +2.68M +21.5% Aug 7, 2017 10-Q 2017-08-07
Q1 2017 15.1M +5.42M +55.8% Mar 30, 2017 10-K 2017-03-30
Q3 2016 12.6M +2.86M +29.5% Nov 14, 2016 10-Q 2016-11-14
Q2 2016 12.5M +2.76M +28.4% Aug 10, 2016 10-Q 2016-08-10
Q1 2016 9.71M +2.82M +41% Mar 30, 2016 10-K 2016-03-30
Q3 2015 9.71M +4.15M +74.5% Nov 13, 2015 10-Q 2015-11-13
Q2 2015 9.71M +4.15M +74.5% Aug 14, 2015 10-Q 2015-08-14
Q1 2015 6.89M Mar 15, 2015 10-K 2015-03-23
Q3 2014 5.57M Nov 11, 2014 10-Q 2014-11-12
Q2 2014 5.57M Jun 10, 2014 10-Q 2014-06-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.